{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:45:44Z","timestamp":1782733544662,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:00:00Z","timestamp":1395360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s12149-014-0840-y","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T11:17:36Z","timestamp":1395314256000},"page":"505-511","source":"Crossref","is-referenced-by-count":19,"title":["Altered biodistribution of FDG in patients with type-2 diabetes mellitus"],"prefix":"10.1007","volume":"28","author":[{"given":"Mehmet A.","family":"Ozguven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper O.","family":"Karacalioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semra","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa O.","family":"Emer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,21]]},"reference":[{"key":"840_CR1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2174\/138955705774575273","volume":"5","author":"SK Das","year":"2005","unstructured":"Das SK, Chakrabarti R. Non-insulin dependent diabetes mellitus: present therapies and new drug targets. Mini Rev Med Chem. 2005;5:1019\u201334.","journal-title":"Mini Rev Med Chem"},{"key":"840_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-09-0260","volume":"204","author":"Y Lin","year":"2010","unstructured":"Lin Y, Sun Z. Current views on type 2 diabetes. J Endocrinol. 2010;204:1\u201311.","journal-title":"J Endocrinol"},{"key":"840_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab. 2010;298:141\u20135.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"840_CR4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nucmedbio.2012.10.014","volume":"40","author":"KA B\u00fcsing","year":"2013","unstructured":"B\u00fcsing KA, Sch\u00f6nberg SO, Brade J, Wasser K. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET\/CT. Nucl Med Biol. 2013;40:206\u201313.","journal-title":"Nucl Med Biol"},{"key":"840_CR5","first-page":"71","volume":"31","author":"S Mirpour","year":"2012","unstructured":"Mirpour S, Meteesatien P, Khandani AH. Does hyperglycemia affect the diagnostic value of 18F-FDG PET\/CT? Rev Esp Med Nucl Imagen Mol. 2012;31:71\u20137.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"840_CR6","first-page":"758","volume":"46","author":"O Israel","year":"2005","unstructured":"Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET\/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758\u201362.","journal-title":"J Nucl Med"},{"key":"840_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2243011214","volume":"224","author":"R Tatlidil","year":"2002","unstructured":"Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783\u20137.","journal-title":"Radiology"},{"key":"840_CR8","first-page":"1804","volume":"45","author":"EM Kamel","year":"2004","unstructured":"Kamel EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET\/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45:1804\u201310.","journal-title":"J Nucl Med"},{"key":"840_CR9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00330-005-0088-y","volume":"16","author":"SJ Rosenbaum","year":"2006","unstructured":"Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake: the role of PET\/CT. Eur Radiol. 2006;16:1054\u201365.","journal-title":"Eur Radiol"},{"key":"840_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.semnuclmed.2003.12.003","volume":"34","author":"GJ Cook","year":"2004","unstructured":"Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET\/CT oncologic imaging. Semin Nucl Med. 2004;34:122\u201333.","journal-title":"Semin Nucl Med"},{"key":"840_CR11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1095-0397(99)00030-8","volume":"2","author":"S Kim","year":"1999","unstructured":"Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging. 1999;2:273\u20139.","journal-title":"Clin Positron Imaging"},{"key":"840_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2967\/jnumed.112.106666","volume":"54","author":"M Massollo","year":"2013","unstructured":"Massollo M, Marini C, Brignone M, Emionite L, Salani B, Riondato M, et al. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J Nucl Med. 2013;54:259\u201366.","journal-title":"J Nucl Med"},{"key":"840_CR13","doi-asserted-by":"crossref","first-page":"13276","DOI":"10.1016\/S0021-9258(19)38295-X","volume":"265","author":"T Kayano","year":"1990","unstructured":"Kayano T, Burant CF, Fukumoto H, Gould GW, Fan YS, Eddy RL, et al. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). J Biol Chem. 1990;265:13276\u201382.","journal-title":"J Biol Chem"},{"key":"840_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2214\/ajr.185.2.01850495","volume":"185","author":"F Gutman","year":"2005","unstructured":"Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET\/CT. AJR. 2005;185:495\u2013500.","journal-title":"AJR"},{"key":"840_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/rg.271065080","volume":"27","author":"HB Prabhakar","year":"2007","unstructured":"Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET\u2013CT. RadioGraphics. 2007;27:145\u201359.","journal-title":"RadioGraphics"},{"key":"840_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003072-199801000-00002","volume":"23","author":"F Miraldi","year":"1998","unstructured":"Miraldi F, Vesselle H, Faulhaber PF, Adler LP, Leisure GP. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med. 1998;23:3\u20137.","journal-title":"Clin Nucl Med"},{"key":"840_CR17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"840_CR18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00259-009-1330-7","volume":"37","author":"T Ozulker","year":"2010","unstructured":"Ozulker T, Ozulker F, Mert M, Ozpacaci T. Clearance of the high intestinal 18F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging. 2010;37:1011\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"840_CR19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/00003495-200363180-00001","volume":"63","author":"RS Hundal","year":"2003","unstructured":"Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs. 2003;63:1879\u201394.","journal-title":"Drugs"},{"key":"840_CR20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-2952(99)00396-2","volume":"59","author":"T Ikeda","year":"2000","unstructured":"Ikeda T, Iwata K, Murakami H. Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine. Biochem Pharmacol. 2000;59:887\u201390.","journal-title":"Biochem Pharmacol"},{"key":"840_CR21","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","volume":"51","author":"CJ Bailey","year":"2008","unstructured":"Bailey CJ, Wilcock C, Scarpello JH. Metformin and the intestine. Diabetologia. 2008;51:1552\u20133.","journal-title":"Diabetologia"},{"key":"840_CR22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0006-2952(95)02243-0","volume":"51","author":"S Lenzen","year":"1996","unstructured":"Lenzen S, Lortz S, Tiedge M. Effect of metformin on SGLT1, GLUT2, and GLUT5 hexose trans-porter gene expression in small intestine from rats. Biochem Pharmacol. 1996;51:893\u20136.","journal-title":"Biochem Pharmacol"},{"key":"840_CR23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2214\/AJR.10.4663","volume":"195","author":"JR Oh","year":"2010","unstructured":"Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, et al. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol. 2010;195:1404\u201310.","journal-title":"AJR Am J Roentgenol"},{"key":"840_CR24","first-page":"234","volume":"48","author":"O Israel","year":"2007","unstructured":"Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, et al. PET\/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake. J Nucl Med. 2007;48:234\u20139.","journal-title":"J Nucl Med"},{"key":"840_CR25","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1073\/pnas.92.13.5817","volume":"92","author":"S Lund","year":"1995","unstructured":"Lund S, Holman GD, Schmitz O, Pederson O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA. 1995;92:5817\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"840_CR26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/jappl.1991.70.4.1593","volume":"70","author":"GD Cartee","year":"1991","unstructured":"Cartee GD, Douen AG, Ramlal T, Klip A, Holloszi JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol. 1991;70:1593\u2013600.","journal-title":"J Appl Physiol"},{"key":"840_CR27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2840-11-63","volume":"11","author":"L Aerni-Flessner","year":"2012","unstructured":"Aerni-Flessner L, Abi-Jaoude M, Koenig A, Payne M, Hruz PW. GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle. Cardiovasc Diabetol. 2012;11:63.","journal-title":"Cardiovasc Diabetol"},{"key":"840_CR28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrm782","volume":"3","author":"NJ Bryant","year":"2002","unstructured":"Bryant NJ, Govers R, James DE. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol. 2002;3:267\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"840_CR29","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.3748\/wjg.v18.i46.6771","volume":"18","author":"S Karim","year":"2012","unstructured":"Karim S, Adams DH, Lalor PF. Hepatic expression and cellular distribution of the glucose transporter family. World J Gastroenterol. 2012;18:6771\u201381.","journal-title":"World J Gastroenterol"},{"key":"840_CR30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1152\/ajpendo.00004.2009","volume":"296","author":"A Leturque","year":"2009","unstructured":"Leturque A, Brot-Laroche E, Le Gall M. GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009;296:985\u201392.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"840_CR31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright EM, Loo DD, Hirayama BA. Biology of human sodium glucose transporters. Physiol Rev. 2011;91:733\u201394.","journal-title":"Physiol Rev"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-014-0840-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-014-0840-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-014-0840-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:01:11Z","timestamp":1648656071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-014-0840-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,21]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1007\/s12149-014-0840-y","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,21]]}}}